S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12

You Can Buy Five Below At Discount Prices, But Wait

Friday, September 3, 2021 | Thomas Hughes
You Can Buy Five Below At Discount Prices, But Wait

Fairly Valued Five Below Gets Cheaper 

Shares of Five Below (NASDAQ: FIVE) entered a correction two weeks ago when Morgan Stanley downgraded the stock to Equal Weight from Over Weight. The reasoning was simple and shouldn’t have sparked the correction it did. According to Morgan Stanley, the stock was fairly valued at $230 with a balanced risk-reward ratio. In that light, a minor pullback may have been expected but not the 17% correction that is now underway. That’s because the company’s Q2 results backed up Morgan Stanley’s decision to cut exposure and gave an additional reason for selling. The guidance, while good, is also aggressive and leaves the door open for a disappointing report next reporting cycle. 

Five Below Has Mixed Quarter, Guides Higher 

Five Below had a good quarter. The company’s store traffic improved along with the reopening and was aided by a strong back-to-school season as well. The company reported $646.55 million in consolidated revenue for a gain of 52.7% over last year and 55% over Q2 2019. The strength was driven by the addition of 34 new stores or +14.2% compounded by double-digit comp sales. The bad news is that revenue missed the consensus by nearly 200 basis points which is a big no-no when other top retailers are easily clearing their hurdles. 

Moving down the report, the company’s profitability improved over the last year as well. The operating income increased nearly 140% on the back of revenue strength and cost-leverage to drive above-consensus results on the bottom line. The GAAP EPS of $0.15 beat the consensus by $0.02 despite the revenue shortfall but the company is expecting margin pressure to begin building. The outlook for the next quarter assumes a seasonal downtick in revenue that will be accompanied by a mild contraction in margins. 

The guidance also assumes a high number of new store openings. The company is projecting 40 to 45 new stores compared to the 34 opened in Q2 and we think that is where the risk lay. The guidance is only marginally higher than the consensus estimates and depends heavily on stores that aren’t yet open. 

The Analysts Cut Five Below’s Price Target 

Five Below is evidence of a trend we’ve seen develop at the tail end of the Q2 reporting season that could cap index gains in the near term. The company delivered a good report but one below the market’s expectations and that is leading the analysts to cut their price targets. Marketbeat.com’s analyst tracking tools show four sell-side analysts, of eighteen covering the stock, lowered their price target in the wake of the Q2 report. The consensus target is still well above the price action but the tide may have turned for this market. If the analysts continue to cut price targets or worse, begin to cut the ratings, shares of Five Below could go much, much lower. 

The Technical Outlook: Five Below Might Reverse 

Price action in Five Below has corrected and may be on the verge of a full reversal. The price action is finding support near the 150-day moving average but it may not hold up. If price action falls below the $190 level and confirms resistance we see this stock falling down to the $160 or $140 level. 
You Can Buy Five Below At Discount Prices, But Wait

Should you invest $1,000 in Five Below right now?

Before you consider Five Below, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Five Below wasn't on the list.

While Five Below currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Five Below (FIVE)2.4$193.91-1.0%N/A42.25Buy$224.00
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.